-
Developing wind power projects in Poland
3 October 2011
Publication
The purpose of this brochure is to give an overview of selected aspects related to the
development of wind power projects in Poland. Due to its general nature, it is highly
advisable to obtain more specific legal advice before commencing any renewable energy
project...
-
Règles de sous-capitalisation : désormais applicables aux prêts bancaires / French thin-capitalization rules now applicable to bank loans
18 January 2011
Publication
La loi de finances pour 2011, qui a été définitivement adoptée, comporte de nouvelles dispositions concernant les règles de sous-capitalisation qui limitent la déductibilité des intérêts supportés...
-
Seconde LFR 2011 : Des dispositions en matière d'IS pénalisantes pour les entreprises / Second Amending Finance Act for 2011 : CIT provisions critical to companies
22 September 2011
Publication
A la suite du plan de réduction des déficits annoncé par François Fillon le 24 août dernier, deux dispositions fiscales importantes intéressant les sociétés soumises à l'impôt sur les sociétés...
-
French Thin-Capitalization Rules
10 March 2011
Publication
Article 113 of the French Finance Act for 2006 (law n° 2005-1719 dated 30 December 2005) has introduced French thin-capitalization rules, codified under Article 212 of the French Tax Code ("FTC"). These rules have given rise to comprehensive comments...
-
UK REITs - the Government confirms changes will be made
18 October 2011
Publication
The UK Government has given its initial response to the Budget REIT consultation.
-
Q&A on the Bribery Act for Private Equity Firms
1 August 2011
Publication
The UK Bribery Act 2010 has been made effective as of 1 July 2011 . The Ministry of Justice's final guidance on the adequate procedures commercial organisations is in place to prevent bribes being paid on their behalf is still expected to be published shortly....
-
Pharma companies and antitrust in China: Part one - merger clearance
1 July 2011
Publication
In the first of two articles on the impact on pharmaceutical companies of China's antitrust regime, we focus on the changing shape of merger control review.
-
Greater China Healthcare and Life Sciences Bulletin: Selected regulatory changes April – June 2011
1 July 2011
Publication
Selected regulatory changes April – June 2011 (English & Chinese)
-
Pharma companies and antitrust in China: Part two – anti-competitive behaviour, abuse of dominance and enforcement trends
1 July 2011
Publication
In this second of two articles exploring the impact of China's antitrust regime on the pharmaceutical industry, we consider in more detail how the day-to-day operations of pharmaceutical companies are affected by China's competition regime, and highlight...
-
NDRC announcement on pricing violations in the pahrmaceutical sector in 2010
1 March 2011
Publication
China's pricing regulator, the National Development and Reform
Commission ("NDRC"), recently published an announcement (the "NDRC
Announcement") ranking the pharmaceutical sector as the worst offender
for pricing violations in 2010...
